News & Events Press Releases Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases Mar 8, 2022 Events January 10, 2022 at 7:00 am EDT H.C. Wainwright 24th Annual Global Investment Virtual Conference
Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases Mar 8, 2022
